Overview

Sorafenib-induced Hand- Foot Skin Reaction Treatment

Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate treatments for a rash caused by sorafenib.
Phase:
Phase 2
Details
Lead Sponsor:
Northwestern University
Collaborator:
Bayer
Treatments:
Emollients
Fluocinonide
Nicotinic Acids
Sorafenib
Tazarotene